Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 4,1814,200 of 20,252 grants

Active NON-SBIR/STTR RPGS
Administrative and Biostatistics Core
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Administrative and Biostatistics Core The overall goal of the Administrative and Biostatistics Core (Admin Core) is to facilitate research efforts toward understa...

Active NON-SBIR/STTR RPGS
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 1: Tumor and Microenvironment Heterogeneity Core The central hypothesis driving efforts of the TMH Core is that immune and other stromal cells in the tumor m...

Active NON-SBIR/STTR RPGS
Core 2: Human Specimen and Organic Core (HSO Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 2: Human Specimen and Organoid Core Patients diagnosed with pancreatic ductal adenocarcinoma (PDA) often fail to respond to therapeutic intervention or rapid...

Active NON-SBIR/STTR RPGS
Core 3: Mouse Models Core (MM Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 3: Mouse Models Core The Mouse Models Core (MM Core) will provide essential, value-added services in support of all P01 projects. As all projects propose pre...

Active NON-SBIR/STTR RPGS
Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
NATIONAL CANCER INSTITUTE Research Inst of Fox Chase Can Ctr United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT The Ras/MAPK pathway is activated in 85% of human cancer. Nevertheless, attempts to target Ras/MAPK signaling have produced only limited efficacy. We hypot...

$7.07M
USD
Completed NON-SBIR/STTR RPGS
Discovery and characterization of exceptionally specific surface oncoprotein LIPI in Ewing Sarcoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

Project Summary Children and young adults with metastatic Ewing sarcoma driven by oncogenic fusion transcription factor EWS- FLI1 continue to have poor outcomes. Immunotherapies us...

$1.9M
USD
Active NON-SBIR/STTR RPGS
The role of inflammation in the regulation of immune response in acute myeloid leukemia
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2023 – 2028

Project Summary/Abstract Survival outcomes of acute myeloid leukemia (AML) patients are negatively affected by high inflammation in the bone marrow compared to low inflammation pat...

$5.7M
USD
Completed NON-SBIR/STTR RPGS
Inhibition and Catalytic Degradation of Promutagenic DNA Deaminases
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

PROJECT SUMMARY This proposal aims to develop the first potent and specific antagonists of the pro-mutagenic effects of APOBEC DNA deaminase enzymes in cells. Access to whole genom...

$1.9M
USD
Active NON-SBIR/STTR RPGS
Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

PROJECT SUMMARY Brief and low-cost family history-based screening assessments to identify families at high risk for BRCA- associated cancers have been endorsed by national guidelin...

$6.16M
USD
Active NON-SBIR/STTR RPGS
The role of translation initiation factor eIF5B in lung cancer pathogenesis
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

PROJECT SUMMARY Lung cancer cells express high levels of PD-L1, a ligand of the PD-1 receptor on T-cells, allowing tumors to directly suppress T cell activity. Anti-PD-1/PD-L1 anti...

$4.76M
USD
Completed SBIR-STTR RPGS
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer
NATIONAL CANCER INSTITUTE Pdx Pharmaceuticals, Inc United States 2023 – 2024

Lung cancer is the leading cause of cancer mortality, exceeding deaths from colon, breast, and prostate cancers combined. Resistance to chemo and targeted therapy is very common. R...

$4M
USD
Active NON-SBIR/STTR RPGS
Overcoming mechanisms of therapeutic resistance in pancreatic ductal adenocarcinoma
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Overall While mortality rates for many cancers are declining, pancreatic ductal adenocarcinoma (PDA) remains a highly lethal malignancy with the worst 5-year surv...

$29.23M
USD
Active NON-SBIR/STTR RPGS
Project 1: Overcoming therapeutic resistance in pancreatic cancer through epigenetic reprogramming
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Project 1: Epigenetics Pancreatic ductal adenocarcinoma (PDA) is a devastating disease with a disturbing rise in incidence. The poor prognosis of PDA is attribute...

Active NON-SBIR/STTR RPGS
Project 2: Targeting signaling networks to overcome therapeutic resistance in pancreatic cancer
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Project 2: Signaling Pancreatic ductal adenocarcinoma (PDA) is most commonly diagnosed at late stages, at which time the disease is refractory to most conventiona...

Active NON-SBIR/STTR RPGS
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Project 3: Autophagy Pancreatic ductal adenocarcinoma (PDA) is one of the deadliest forms of cancer with few effective therapies. The poor performance of current...

Active NON-SBIR/STTR RPGS
Administrative and Biostatistics Core
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Administrative and Biostatistics Core The overall goal of the Administrative and Biostatistics Core (Admin Core) is to facilitate research efforts toward understa...

Active NON-SBIR/STTR RPGS
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 1: Tumor and Microenvironment Heterogeneity Core The central hypothesis driving efforts of the TMH Core is that immune and other stromal cells in the tumor m...

Active NON-SBIR/STTR RPGS
Core 2: Human Specimen and Organic Core (HSO Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 2: Human Specimen and Organoid Core Patients diagnosed with pancreatic ductal adenocarcinoma (PDA) often fail to respond to therapeutic intervention or rapid...

Active NON-SBIR/STTR RPGS
Core 3: Mouse Models Core (MM Core)
NATIONAL CANCER INSTITUTE Salk Institute for Biological Studies United States 2023 – 2028

PROJECT SUMMARY – Core 3: Mouse Models Core The Mouse Models Core (MM Core) will provide essential, value-added services in support of all P01 projects. As all projects propose pre...

Completed NON-SBIR/STTR RPGS
Discovery and characterization of exceptionally specific surface oncoprotein LIPI in Ewing Sarcoma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

Project Summary Children and young adults with metastatic Ewing sarcoma driven by oncogenic fusion transcription factor EWS- FLI1 continue to have poor outcomes. Immunotherapies us...

$2.17M
USD